Motion mitigation for scanned protons

Proton therapy delivered via active scanning can provide the high radiation doses needed to treat stage I-III lung cancer more effectively than intensity-modulated radiotherapy (IMRT) or passively scattered protons. But targeting a tumour in motion can be a hit or miss proposition. A research team from Massachusetts General Hospital has tested motion mitigation techniques for this promising treatment.